首页> 美国卫生研究院文献>Asian Journal of Pharmaceutical Sciences >Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method
【2h】

Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method

机译:通过与行星珠磨共研磨活性药物普罗布考和三元稳定剂混合物改善溶出度和口服吸收

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this work is to construct a nanosuspension drug delivery system of probucol, a BCS II drug, in order to improve its dissolution and oral bioavailability. The wet milling procedure using planetary beads-milling equipment was utilized to grind the raw probucol to ultrafine nanoparticleanocrystal aqueous suspension that was further solidified by freeze-drying process. Cellulose derivatives of different substitution groups and molecular weights, including HPMC, HPC, and MC, were evaluated as the primary stabilizer of probucol nanosuspension. Ternary stabilizers system composed of a primary stabilizer (cellulose derivative, HPC), a nonionic surfactant (Pluronic® F68), and an anionic surfactant (SDS) was employed to obtain probucol nanosuspension of finer particle size and enhanced dissolution in aqueous media. The probucol nanosuspension with good physical stability showed no obvious change of particle size even after storing over 7 d at 4 °C or 25 °C. The solidified probucol nanosuspension with trehalose as the cryoprotectant showed the highest dissolution rate (> 60% at 2 h) compared to other cryoprotectant. The pharmacokinetic evaluation indicated about 15-folds higher value of the probucol nanosuspension compared to that of coarse probucol suspension after oral administration to rats. The probucol nanosuspension prepared by wet-milling and ternary stabilizers system may find wide applications for improving the dissolution and oral absorption of water-insoluble drugs.
机译:这项工作的目的是构建丙丁酚(一种BCS II药物)的纳米悬浮药物递送系统,以改善其溶出度和口服生物利用度。利用行星式球磨设备的湿磨程序将粗制普罗布考研磨成超细的纳米颗粒/纳米晶体水悬浮液,然后通过冷冻干燥工艺使其固化。评估了不同取代基和分子量的纤维素衍生物(包括HPMC,HPC和MC)作为普罗布考纳米悬浮液的主要稳定剂。由主要稳定剂(纤维素衍生物,HPC),非离子表面活性剂(F68)和阴离子表面活性剂(SDS)组成的三元稳定剂体系用于获得更细粒度的普罗布考纳米悬浮液,并增强了在水性介质中的溶解度。具有良好物理稳定性的普罗布考纳米悬浮液即使在4°C或25°C下保存7天以上,也没有显示出明显的粒径变化。与其他冷冻保护剂相比,以海藻糖作为冷冻保护剂的固化普罗布考纳米悬浮液显示出最高的溶解速率(在2 h时> 60%)。药代动力学评估表明,与大鼠口服给药后的粗普罗布考悬浮液相比,普罗布考纳米悬浮液的价值高约15倍。通过湿磨和三元稳定剂系统制备的普罗布考纳米混悬剂可广泛用于改善水不溶性药物的溶解和口服吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号